Article
Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity.
Human molecular genetics - 15 Jan 2007
West Andrew B, Moore Darren J, Choi Catherine, Andrabi Shaida A, Li Xiaojie, Dikeman Dustin, Biskup Saskia, Zhang Zhenshui, Lim Kah-Leong, Dawson Valina L, Dawson Ted M
Abstract excerpt
Mutations in the leucine-rich repeat kinase 2 gene (LRRK2) cause late-onset Parkinson's disease indistinguishable from idiopathic disease. The mechanisms whereby missense alterations in the LRRK2 gene initiate neurodegeneration remain unknown. Here, we demonstrate that seven of 10 suspected familial-linked mutations result in increased kinase activity. Functional and disease-associated mutations in conserved...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
